An van Es-Johansson
Dr. An van Es-Johansson, M.D. has served as a member of our Board since February 2021. Dr. van Es-Johansson currently serves as a senior advisor for start up companies. Dr. van Es-Johansson was previously the Chief Medical Officer and Head of Development for AlzeCure Pharma from 2018 to 2021. From 2005 to 2018, Dr. van Es-Johansson served in a range of executive roles of increasing responsibility at Sobi, an international rare disease company headquartered in Stockholm, Sweden. Dr. van Es-Johansson also served as a member of the Scientific Advisory board for Uppsala Bio from 2004 to 2016 and currently also serves on the Board of Directors at Savara Inc., PLUS Therapeutics , Agendia BV and IRLAB . Dr. van Es-Johansson received an M.D. from Erasmus University, Rotterdam, The Netherlands.